The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories
NCT03031405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2018-08-21
Summary
The purpose of the study is to examine whether oxytocin and oxytocin receptor gene polymorphism affect the development of intrusive memories, a cardinal symptom of PTSD.
Conditions
- Intrusive Memories
Interventions
- DRUG
-
Oxytocin nasal spray
- DRUG
-
Placebos
Placebo nasal spray
Sponsors & Collaborators
-
Central Institute of Mental Health, Mannheim
collaborator OTHER -
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Stefan Roepke, PD Dr. · Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-15
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Cortisol and the Formation of Intrusive Memories
NCT02552654 ·Status: COMPLETED ·Phase: NA
-
Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
NCT01681849 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
NCT01492699 ·Status: COMPLETED ·Phase: NA
-
Influence of the Noradrenergic System on the Formation of Intrusive Memories
NCT02541071 ·Status: COMPLETED ·Phase: NA
-
The Role of Expectations in the Development of Intrusive Memories
NCT03950869 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Affect Processing in Posttraumatic Stress Disorder
NCT02546570 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep and Wellbeing Study
NCT03012685 ·Status: COMPLETED
-
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT00203463 ·Status: COMPLETED ·Phase: PHASE4
-
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
NCT00383786 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin to Treat PTSD
NCT04228289 ·Status: COMPLETED ·Phase: PHASE2
-
Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder
NCT01108133 ·Status: COMPLETED ·Phase: NA
-
Sleep's Influence on the Treatment of Intrusive Emotional
NCT05678361 ·Status: COMPLETED ·Phase: NA
-
Neural Correlates of Stress Hormones
NCT02523664 ·Status: COMPLETED ·Phase: NA
-
Explanation About Sleep in Post Trauma Patients
NCT01684085 ·Status: UNKNOWN ·Phase: NA
-
Enhancing Memory in CPT for PTSD
NCT06000475 ·Status: RECRUITING ·Phase: NA
-
Reducing Reconsolidation of Trauma Memories With Propranolol
NCT01349439 ·Status: UNKNOWN ·Phase: PHASE2
-
A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol
NCT00709735 ·Status: COMPLETED ·Phase: PHASE4
-
Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder
NCT04508166 ·Status: COMPLETED ·Phase: NA
-
Characterization and Modulation of Traumatic Memories in PTSD Patients Using TMS
NCT06372639 ·Status: COMPLETED ·Phase: NA
-
Brief Cognitive Behavioral Conjoint Therapy for PTSD With Adjunctive Intranasal Oxytocin
NCT05207436 ·Status: COMPLETED ·Phase: PHASE2
-
Propranolol Treatment of Traumatic Memories (PTTM)
NCT01069159 ·Status: UNKNOWN ·Phase: NA
-
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
NCT06194851 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)
NCT00672776 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Post Traumatic Stress Disorder by Early Treatment
NCT00146900 ·Status: COMPLETED ·Phase: NA
-
Perception of Stressful Social Stimuli After Trauma Exposure.
NCT03421587 ·Status: COMPLETED